https://stoicvc.com.au/wp-content/uploads/2023/10/Research-scaled.jpg17092560Harikesh Pushpapathanhttps://stoicvc.com.au/wp-content/uploads/2023/04/Screen-Shot-2023-04-25-at-5.44.30-pm-300x137.pngHarikesh Pushpapathan2023-10-26 11:09:402023-10-26 11:12:26US FDA has granted Orphan Drug Designation to Certa Therapeutics’ lead candidate FT011 for treatment of Systemic Sclerosis
